Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sara,Panigone

第一单位： Corporate Marketing, Chiesi Farmaceutici SpA, Parma, Italy s.panigone@chiesi.com.

作者： Sara,Panigone ^[1] ; Federica,Sandri ^[2] ; Rossella,Ferri ^[3] ; Andrea,Volpato ^[3] ; Elena,Nudo ^[4] ; Gabriele,Nicolini ^[4]

作者单位： Corporate Marketing, Chiesi Farmaceutici SpA, Parma, Italy s.panigone@chiesi.com. ^[1] Corporate Marketing, Chiesi Farmaceutici SpA, Parma, Italy. ^[2] Corporate Health Safety & Environment, Chiesi Farmaceutici SpA, Parma, Italy. ^[3] Global Medical Affairs, Chiesi Farmaceutici SpA, Parma, Italy. ^[4]

关键词 Asthma COPD pharmacology inhaler devices

主题词投药, 吸入(Administration, Inhalation);肾上腺素能β激动剂(Adrenergic beta-Agonists);哮喘(Asthma);碳足迹(Carbon Footprint);人类(Humans);雾化器和汽化器(Nebulizers and Vaporizers);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive)

DOI 10.1136/bmjresp-2020-000571

PMID 32238349

发布时间 2024-07-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

BMJ open respiratory research

2020年7卷1期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment.

BMJ open respiratory research

相似文献

BMJ open respiratory research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment.

BMJ open respiratory research

相似文献

BMJ open respiratory research

相关期刊

检索历史清除